Clarity Pharmaceuticals Signs Copper-67 Supply Agreement with Idaho State University’s Idaho Accelerator Center
Sydney, Australia 13 March 2020 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the signing of a Product Supply Agreement with the Idaho State University Idaho Accelerator Center (IAC) for the production and commercial supply of copper-67 (Cu-67). Under the new agreement, IAC will supply Clarity…